The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor
Conditions: Doxorubicin Adverse Reaction; Cardiomyopathies, Secondary; Breast Cancer Intervention: Sponsor: Rush University Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials